1. Jose Iglesias: The next "thing" in the Boston lineup, Iglesias is going to be in the major sometime this year. Although whether he will succeed is yet to be seem, the obstacle ahead of him shouldn't be hard to overcome. As Jed Lowrie and Marco Scutaro both seem to only be temporary solution for the post. Iglesias' key card is the 2010 Bowman Chrome Auto, which is already on the rise since spring training. However, given the uniform he's going to be waring, there's still plenty of potential to climb. All the boost it might need is the rumor of call up and a week in the Boston starting line up, which is more than likely to happen sometime before all star break. The card should rise, albeit a 50% spike for two weeks or a 500% climb all through the end of the season is still unknown. Adding by the fact that the chrome auto is the only autograph there is, it is a very nice and mostly safe investment at this time. (short term: A, long term: B, spike rate: A)
2. Anthony Ranaudo: Being a colleage first round pick means the outcome of any Ranaudo investment should come fast and hard, whether at either direction. Has yet to pitch in the pros, looks like to start the season in extended ST or short A-ball, which will dip his price either way for being out of spot light. Having only Elite and ITG issue is no help either, because neither will maintain their current price should he struggles or if the Chrome issue comes along. Having almost no chance to go upward, and the fact that the current issue isn't ideal long term possession, I wouldn't try to buy or keep any of them at this time. (short term: C-, long term: C+, spike rate: D)
3. Drake Britton: In A ball last year, Britton is the same age as Ranaudo and seems to be ranked right behind him as the best pitching prospect in the system. Currently, Britton only has TriStar and AFLAC stuff, and his BC auto will be out in May. When they does, he's performance in the first two month will set the price for the card and should be stable all through the season baring injury. BA predicts he's ETA in 2013, meaning any possession you might have of him is unlikely to cash for a while. If you like what you see in him this season, the time to buy should be in Dec, not May, although holding what you already have is also a fine idea as the market should be dry soon after the initial release. (short term: C, long term: C+, spike rate: C)
4. Yamaico Navarro: Only a C+ prospect in Sickels' ranking, Navarro is in here only because he somehow crack the PP top 100 list at No. 95. He's already proof he can handle AAA playing doing a little bit of everything, although he's brief AB in Boston last season is nothing to write home about. Navarro's postion in the bigs is already occupied by Youkilis, so he's chance to be in the Boston starting line up is very gloom. Unless Youkilis goes on the DL this season, Yamaico's card should be in the common slot for the duration of the season. (short: C, long term: C-, spike rate: C+)
5. Brandon Workman: Being Boston's second round pick last year, Workman is another colleage prospect just like Ranaudo whom also has yet to make his professional debut. He should start the season wherever Ranaudo does and his teammate all year. Although concesus seems to think Ranaudo is much better a prospect, in my book, they're both the same until we can see some professional stats. Having only Elite auto and being pretty much dirt cheap (blue aspiration #/100 only sold for $7), he's a much better buy for the cost is drastically lower for only a slight lower chance of success. (short term: B-, long term: B-, spike rate: C)
6. Chris Balcom-Miller: (short term: B, long term: B-, spike rate: B)
7. Garin Cecchini: (short term: C, long term: C-, spike rate: C)
8. Josh Reddick: (short term: C+, long term: C, spike rate: B+)
9. Kolbrin Vitek: (short term: B-, long term: C+, spike rate: C)
10. Oscar Tejeda: (short term: B-, long term: C+, spike rate: C+)
11. Ryan Lavarnway: (short term: B, long term: B, spike rate: B)
12. Stomy Pimentel: (short term: C, long term: C-, spike rate: C+)
13. Felix Doubront: (short term: B-, long term: B-, spike rate: B-)
14. Wil Middlebrooks: (short term: C-, long term: C, spike rate: C+)
